Pediatric Cardiology

This channel includes news regarding new technologies used in the specialized care for diagnosing and treating children with heart conditions. This includes advanced diagnostics for evaluating and treating pediatric heart conditions such as congenital heart defects, cardiac arrhythmias and acquired heart diseases.

Researchers analyzing surveillance data on 518 children and adolescents with MIS-C who were admitted to U.S. hospitals in 2020 fopiund those treated with intravenous immune globulin (IVIG) plus glucocorticoids had a lower risk of new or persistent cardiovascular dysfunction than IVIG alone. Left photo Getty Images, right photo Nemours Children’s Health System.

News | Coronavirus (COVID-19)

Study Provides MIS-C Treatment Guidance To Avoid Cardiovascular Dysfunction

June 28, 2021 - A recent analysis found that children and adolescents with multisystem inflammatory syndrome in children ...

June 28, 2021

News | Antiplatelet and Anticoagulation Therapies

FDA Clears Pradaxa as First Oral Anticoagulant for Children

June 21, 2021 — The U.S. Food and Drug Administration (FDA) approved Boehringer Ingelheim's dabigatran etexilate ...

June 21, 2021

PolyVascular, leading the effort to improve children's lives with a novel polymeric transcatheter valve (PTV) for children, announced that it was awarded a $2 million Small Business Innovation Research (SBIR) Phase II grant earlier this year to bring its polymeric stent-mounted valve (SMV) to clinical trials within the next two years in an effort to address pediatric congenital heart disease (CHD), which affects over 1 million patients around the world.

News | Pediatric Cardiology

PolyVascular Awarded $2 Million Small Business Innovation Research Grant to Bring the First Polymer-Based Heart Valve for Children to Clinical Trials

May 13, 2021 — PolyVascular, leading the effort to improve children's lives with a novel polymeric transcatheter valve ...

May 13, 2021

University of Minnesota researchers used a hybrid of tissue engineering and regenerative medicine to create heart valves that can grow with the recipient. When implanted in lambs, researchers showed that the tri-tube valves worked better than current animal-derived valves with almost none of the calcification or blood clotting that the other valves showed. This can be implanted in pediatric patients with congenital heart diseas. Photo from Syedain, et al., Tranquillo Lab, University of Minnesota

News | Heart Valve Technology

Lab-created Heart Valves Can Grow With the Patient

March 18, 2020 — A groundbreaking new study led by University of Minnesota Twin Cities researchers from both the College ...

March 18, 2021

News | Congenital Heart

More Than 50,000 Children Screened for Congenital Heart Defects Using AI-enabled Stethoscopes

February 16, 2021 – In recognition of World Congenital Heart Defects (CHD) Awareness week, HD Medical Inc. announced it ...

February 16, 2021

Coronavirus SARS-CoV-2 colorized scanning electron micrograph of a cell (pink) heavily infected with SARS-CoV-2 virus particles (teal and purple), isolated from a patient sample. Image courtesy of NIAID. MIS-C Multisystem inflammatory syndrome in children. #COVID19

News | Coronavirus (COVID-19)

NIH Begins Study of COVID Infection and Multisystem Inflammatory Syndrome in Children (MIS-C)

December 22, 2020 — An observational study has launched to evaluate the short- and long-term health outcomes of SARS-CoV ...

December 22, 2020

HeartMate 3 heart pump is now approved for use for pediatric patients battling advanced heart failure offering a new treatment option for this underserved population

News | Heart Failure

FDA Approves Abbott's HeartMate 3 VAD for Pediatric Patients

December 21, 2020 — U.S. Food and Drug Administration (FDA) approved updated labeling December 17 for Abbott's HeartMate ...

December 21, 2020

cyanosis, cyantosis COVID-positive infant.

News | Coronavirus (COVID-19)

COVID-19 Can Impact Hearts in Young Children

December 2, 2020 — A 2-month-old infant diagnosed with COVID-19 (SARS-CoV-2) experienced reversible myocardial injury ...

December 02, 2020